Companies › ORIC

ORIC PHARMACEUTICALS INC (ORIC)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001796280 · EDGAR filings · Updated 2026-07-28

ORIC PHARMACEUTICALS INC (ORIC) has reported institutional ownership of 115.3%, with 182 institutional managers holding positions valued at $1.51B per the latest 13F reporting period.

Filings this week (1)

• 2026-07-28 — Insider transaction reported (Form 4)

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-08 — Insider transaction reported (Form 4)
• 2026-07-06 — Notice of proposed sale filed (Form 144)
• 2026-07-06 — Notice of proposed sale filed (Form 144)
• 2026-06-22 — Current report (8-K) filed
• 2026-05-15 — SCHEDULE 13G/A filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, ORIC PHARMACEUTICALS INC has 182 institutional holders and institutional ownership of 115.3%.

Insider activity

Insiders reported 32 transactions (2 buys, 21 sells) across 6 reporting insiders, with a net reported value of −$4.66M.

Related companies

ESTABLISHMENT LABS HLDGS INC (ESTA) · OLEMA PHARMACEUTICALS INC (OLMA) · PACS GROUP (PACS) · TANDEM DIABETES CARE INC COM NEW (TNDM) · DEFINIUM THERAPEUTICS F (DFTX) · ATRICURE INC (ATRC)